Inovio Pharma (INO) to Offer $150M in Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Inovio Pharma (INO) Prices 17.7M Share Common Offering at $8.50/Sh
January 21, 2021 6:00 AM ESTINOVIO Pharmaceuticals, Inc. (NASDAQ: NIO) today announced the pricing of an underwritten public offering of 17,700,000 shares of its common stock at a public offering price of $8.50 per share. In addition, INOVIO has granted the underwriters a 30-day option to purchase up to an additional 2,655,000 shares of common stock at the public... More
Inovio Pharma (INO) Shares Are Said to be Offered at $8.50 to $9 Each - Bloomberg
January 20, 2021 4:56 PM ESTInovio Pharma (NASDAQ: INO) Shares Are Said to be Offered at $8.50 to $9 Each - Bloomberg
